| Unified criteria for ultrasonographic diagnosis of ADPKD Y Pei, J Obaji, A Dupuis, AD Paterson, R Magistroni, E Dicks, P Parfrey, ... Journal of the American Society of Nephrology 20 (1), 205-212, 2009 | 843 | 2009 |
| Comparison of phenotypes of polycystic kidney disease types 1 and 2 N Hateboer, MA v Dijk, N Bogdanova, E Coto, AK Saggar-Malik, ... The Lancet 353 (9147), 103-107, 1999 | 713 | 1999 |
| Treatment of Fabry’s disease with the pharmacologic chaperone migalastat DP Germain, DA Hughes, K Nicholls, DG Bichet, R Giugliani, WR Wilcox, ... New england journal of medicine 375 (6), 545-555, 2016 | 587 | 2016 |
| Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference AB Chapman, O Devuyst, KU Eckardt, RT Gansevoort, T Harris, S Horie, ... Kidney international 88 (1), 17-27, 2015 | 587 | 2015 |
| Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia CJ Ward, D Yuan, TV Masyuk, X Wang, R Punyashthiti, S Whelan, ... Human molecular genetics 12 (20), 2703-2710, 2003 | 394 | 2003 |
| Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy O Gross, C Licht, HJ Anders, B Hoppe, B Beck, B Tönshoff, B Höcker, ... Kidney international 81 (5), 494-501, 2012 | 374 | 2012 |
| Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA ERACODA Working Group Duivenvoorden Raphaël Franssen Casper FM Hemmelder ... Nephrology Dialysis Transplantation 36 (1), 87-94, 2021 | 359 | 2021 |
| Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney … RT Gansevoort, M Arici, T Benzing, H Birn, G Capasso, A Covic, ... Nephrology Dialysis Transplantation 31 (3), 337-348, 2016 | 317 | 2016 |
| Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome S Santín, G Bullich, B Tazón-Vega, R García-Maset, I Giménez, I Silva, ... Clinical Journal of the American Society of Nephrology 6 (5), 1139-1148, 2011 | 283 | 2011 |
| Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival—an analysis of data from the ERA-EDTA Registry EM Spithoven, A Kramer, E Meijer, B Orskov, C Wanner, JM Abad, ... Nephrology Dialysis Transplantation 29 (suppl_4), iv15-iv25, 2014 | 267 | 2014 |
| An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document JM Campistol, M Arias, G Ariceta, M Blasco, L Espinosa, M Espinosa, ... Nefrología (English Edition) 35 (5), 421-447, 2015 | 245 | 2015 |
| Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue ACM Ong, CJ Ward, RJ Butler, S Biddolph, C Bowker, R Torra, Y Pei, ... The American journal of pathology 154 (6), 1721-1729, 1999 | 233 | 1999 |
| An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document JM Campistol, M Arias Ballesteros, G Ariceta, M Blasco, M Espinosa, ... Sociedad Española de Nefrología, 2013 | 197 | 2013 |
| Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. R Torra, C Badenas, A Darnell, C Nicolau, V Volpini, L Revert, X Estivill Journal of the American Society of Nephrology 7 (10), 2142-2151, 1996 | 196 | 1996 |
| Screening, diagnosis, and management of patients with Fabry disease: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference R Schiffmann, DA Hughes, GE Linthorst, A Ortiz, E Svarstad, DG Warnock, ... Kidney international 91 (2), 284-293, 2017 | 187 | 2017 |
| Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD M Vujic, CM Heyer, E Ars, K Hopp, A Markoff, C Örndal, B Rudenhed, ... Journal of the American Society of Nephrology 21 (7), 1097-1102, 2010 | 182 | 2010 |
| Patients with multiple myeloma requiring long‐term dialysis: presenting features, response to therapy, and outcome in a series of 20 cases R Torra, J Blade, A Cases, J López‐Pedret, E Montserrat, C Rozman, ... British journal of haematology 91 (4), 854-859, 1995 | 176 | 1995 |
| Nephrin mutations cause childhood-and adult-onset focal segmental glomerulosclerosis S Santín, R García-Maset, P Ruíz, I Giménez, I Zamora, A Pena, A Madrid, ... Kidney international 76 (12), 1268-1276, 2009 | 175 | 2009 |
| Mutations in theCOL4A4 and COL4A3 genes cause familial benign hematuria M Praga, B Tazón, L Heidet, C Arrondel, A Armengol, A Andrés, ... Journal of the American Society of Nephrology 13 (5), 1248-1254, 2002 | 166 | 2002 |
| Expert consensus guidelines for the genetic diagnosis of Alport syndrome J Savige, F Ariani, F Mari, M Bruttini, A Renieri, O Gross, C Deltas, ... Pediatric Nephrology 34, 1175-1189, 2019 | 157 | 2019 |
